silybin has been researched along with Cancer of Ovary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abazari, O; Abbasi, M; Ebrahimi, M; Eskandari, Y; Faisal Faiz, A; Gravand, A; Khosh Ravesh, R; Lorian, K; Maleki, N; Panji, M; Shafiee Mehr, M; Sharbati, A; Yavari, N | 1 |
| Dong, X; Feng, H; Lin, X; Liu, Q; Wei, Z; Yao, J; Ye, S; Zeng, C; Zeng, L; Zeng, X | 1 |
| Bakhshaei, A; Eskandani, M; Jafari, S; Molavi, O | 1 |
| Hirasawa, T; Ishimoto, H; Katoh, T; Mikami, M; Miyazawa, M; Ogane, N; Yano, M; Yasuda, M | 1 |
| Chen, B; Liu, J; Meng, W; Zhang, H; Zhou, L | 1 |
| Akbarzadeh, A; Ebrahimie, E; Khodadadi, K; Pashaei-Asl, F; Pashaei-Asl, R; Pashaiasl, M | 1 |
| Cho, HJ; Choi, KU; Kim, KH; Kim, YK; Moon, SH; Park, DY; Song, YJ; Suh, DS; Yoon, MS | 1 |
| Alimoghaddam, K; Ghaffari, SH; Ghasemi, R; Ghavamzadeh, A; Javadikooshesh, S; Miranda, M; Momeny, M; Valenti, G; Yaghmaie, M; Zarrinrad, G; Zekri, A | 1 |
8 other study(ies) available for silybin and Cancer of Ovary
| Article | Year |
|---|---|
Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT).
Topics: Animals; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Ovarian Neoplasms; Silybin; Xenograft Model Antitumor Assays | 2022 |
Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Female; Humans; Isocitrate Dehydrogenase; Mice; Mutation; NADP; Ovarian Neoplasms; Silybin | 2022 |
Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells.
Topics: Cell Line, Tumor; Cisplatin; Drug Carriers; Female; Humans; Lipids; Ovarian Neoplasms; Silybin | 2022 |
Hypoxia-inducible Factor-1α Suppression in Ovarian Clear-cell Carcinoma Cells by Silibinin Administration.
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Agents, Phytogenic; Biomarkers; Cell Hypoxia; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; L-Lactate Dehydrogenase; Ovarian Neoplasms; Signal Transduction; Silybin | 2020 |
Evaluation of Silibinin-Loaded Microbubbles Combined with Ultrasound in Ovarian Cancer Cells: Cytotoxicity and Mechanisms.
Topics: Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Microbubbles; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Silybin | 2022 |
Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Paclitaxel; Silybin; Silymarin; Tumor Suppressor Proteins | 2018 |
Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and Akt in vitro and in vivo in human ovarian cancer cells.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Caspase 3; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Silybin; Silymarin | 2013 |
Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.
Topics: Antioxidants; Blotting, Western; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA, Neoplasm; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Neuregulin-1; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Receptor, ErbB-3; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Silybin; Silymarin; Survivin | 2016 |